Overview

• The Guangzhou startup presented its “gestation robot” concept in Beijing, with founder Zhang Qifeng outlining the idea of a humanoid carrying a pregnancy outside the human body.
• Kaiwa describes an internal chamber with synthetic amniotic fluid, nutrient tubing, and a machine‑grown placenta, and it cites a target price near 100,000 yuan with a prototype goal as early as 2026.
• The company has not disclosed any testing with human eggs, sperm, or embryos, and no peer‑reviewed data, clinical trials, or independent medical validation have been released.
• China’s rules limit embryo development outside the body to 14 days and restrict commercial surrogacy, and Kaiwa says it has submitted proposals to Guangdong authorities seeking a policy pathway.
• Medical and ethics experts question feasibility, safety, and child welfare, highlighting unresolved hurdles such as implantation and placenta function despite earlier animal ectogenesis work in 2017.